Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets

Abstract

Background: Circular RNAs (circRNAs), as covalently closed single-stranded noncoding RNA molecules, have been recently identified to involve in several biological processes, principally through targeting microRNAs. Among various neurodegenerative diseases (NDs), accumulating evidence has proposed key roles for circRNAs in the pathogenesis of Alzheimer’s disease (AD); although the exact relationship between these RNA molecules and AD progression is not clear, they have been believed to mostly act as miRNA sponges or gene transcription modulators through correlating with multiple proteins, involved in the accumulation of Amyloid β (Aβ) peptides, as well as tau protein, as AD’s pathological hallmark. More interestingly, circRNAs have also been reported to play diagnostic and therapeutic roles during AD progression. Objective: Literature review indicated that circRNAs could essentially contribute to the onset and development of AD. Thus, in the current review, the circRNAs’ biogenesis and functions are addressed at first, and then the interplay between particular circRNAs and AD is comprehensively discussed. Eventually, the diagnostic and therapeutic significance of these noncoding RNAs is highlighted in brief. Results: A large number of circRNAs are expressed in the brain. Thereby, these RNA molecules are noticed as potential regulators of neural functions in healthy circumstances, as well as neurological disorders. Moreover, circRNAs have also been reported to have potential diagnostic and therapeutic capacities in relation to AD, the most prevalent ND. Conclusion: CircRNAs have been shown to act as sponges for miRNAs, thereby regulating the function of related miRNAs, including oxidative stress, reduction of neuroinflammation, and the formation and metabolism of Aβ, all of which developed in AD. CircRNAs have also been proposed as biomarkers that have potential diagnostic capacities in AD. Despite these characteristics, the use of circRNAs as therapeutic targets and promising diagnostic biomarkers will require further investigation and characterization of the function of these RNA molecules in AD.

Are Ischemic Stroke and Alzheimer’s Disease Genetically Consecutive Pathologies?

“…The study and application of the circRNAs properties in the context of IS and AD is highly relevant. This is primary due to the diverse and unique properties of circRNAs, which hold promise for enhancing the existing methods for preventing IS and AD as well as managing the consequences of these diseases [194,195]. Moreover, the properties of circRNAs as new important regulators in the nervous system may underlie the phenomenon of the interconnectedness of neuropathologies, in particular IS and AD.…”

Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications

“…As we know, ncRNAs, including miRNAs, lncRNAs, and circRNAs contribute to a vast array of genetic modulatory mechanisms [ 85 , 86 ]. In this era, researchers have tried to elucidate these regulatory pathways that are related to ferroptosis and fortunately have discovered valuable information.…”

The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms

“…In addition to being involved in cancer progression, exosomal ncRNAs have been demonstrated to contribute to the onset of metabolic disorders, including osteoporosis, type 2 diabetes mellitus (T2DM) and diabetic nephropathy, and obesity ( Li et al, 2021a ; Mafi et al, 2021 ). NcRNAs are also involved in the pathogenesis and progression of neurodegenerative diseases, such as Parkinson’s and Alzheimer’s diseases ( Jea et al, 2019 ; Dorostgou et al, 2022 ; Vakili et al, 2023 ). NcRNAs encapsulated in exosomes are even associated with infectious diseases (e.g., viral hepatitis) and autoimmune disorders, such as rheumatoid arthritis (RA) ( Wang et al, 2018b ; Jiao et al, 2021 ).…”